PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11505807-2	2001	This study aimed to determine if one month of therapy with loratadine 10 mg once daily would also induce any decrease in serum levels of soluble ICAM-1 (sICAM-1) or VCAM-1 (sVCAM-1).	Loratadine	59-69	vascular cell adhesion molecule 1	Homo sapiens	165-171	
11763722-9	2001	Patients receiving loratadine showed significant decreases in serum VCAM-1 levels (p = 0.0012) but not in serum ICAM-1 levels (p = 0.224).	Loratadine	19-29	vascular cell adhesion molecule 1	Homo sapiens	68-74	
11763722-11	2001	CONCLUSIONS: Specific house dust mite immunotherapy and regular daily loratadine therapy are able to lower significantly serum levels of soluble VCAM-1.	Loratadine	70-80	vascular cell adhesion molecule 1	Homo sapiens	145-151	
30119218-6	2018	The presence of loratadine in endothelial culture efficiently suppressed ox-LDL-induced attachment of monocytes to endothelial cells, production of ROS and vascular adhesion molecules, and induction cytokines including VCAM-1, E-selectin, TNF-alpha, IL-6 and IL-8.	Loratadine	16-26	vascular cell adhesion molecule 1	Homo sapiens	219-225